List of CSL Limited patents

List of CSL Limited patents

List of Alsons Corporation patents

List of Early Warning Services patents

List of Hyliion patents

Companies in the Metalworking Machinery Manufacturing industry

List of awards received by Rachel McAdams

Patents where

Current Assignee

Name

is

CSL Limited

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11505619 Use of a FXIIa-inhibitor in the treatment of renal fibrosis and/or chronic kidney disease	Patent 11505619 was granted and assigned to CSL Limited on November, 2022 by the United States Patent and Trademark Office.	CSL Limited	CSL Limited		United States Patent and Trademark Office	11505619	November 22, 2022
	‌ US Patent 11058747 Reconstituted high density lipoprotein formulation and production method thereof	Patent 11058747 was granted and assigned to CSL Limited on July, 2021 by the United States Patent and Trademark Office.	CSL Limited	CSL Limited		United States Patent and Trademark Office	11058747	July 13, 2021
	‌ US Patent 11279750 Process for preparing apolipoprotein A-I (Apo A-I)		CSL Limited	CSL Limited		United States Patent and Trademark Office	11279750	March 22, 2022
	‌ US Patent 11510968 Method for improving the stability of purified Factor VIII after reconstitution	Patent 11510968 was granted and assigned to CSL Limited on November, 2022 by the United States Patent and Trademark Office.	CSL Limited	CSL Limited		United States Patent and Trademark Office	11510968	November 29, 2022
	‌ US Patent 7534441 Immunogenic LHRH compositions and methods relating thereto	Patent 7534441 was granted and assigned to CSL Limited on May, 2009 by the United States Patent and Trademark Office.		CSL Limited		United States Patent and Trademark Office	7534441	May 19, 2009
	‌ US Patent 11466073 Human serum albumin variants and uses thereof		CSL Limited	CSL Limited		United States Patent and Trademark Office	11466073	October 11, 2022
	‌ US Patent 10894834 CD131 binding proteins	Patent 10894834 was granted and assigned to CSL Limited on January, 2021 by the United States Patent and Trademark Office.	CSL Limited	CSL Limited		United States Patent and Trademark Office	10894834	January 19, 2021
	‌ US Patent 11464828 Reconstituted HDL formulation	Patent 11464828 was granted and assigned to CSL Limited on October, 2022 by the United States Patent and Trademark Office.	CSL Limited	CSL Limited		United States Patent and Trademark Office	11464828	October 11, 2022
	‌ US Patent 10881717 Method for improving the stability of purified Factor VIII after reconstitution	Patent 10881717 was granted and assigned to CSL Limited on January, 2021 by the United States Patent and Trademark Office.	CSL Limited	CSL Limited		United States Patent and Trademark Office	10881717	January 5, 2021
	‌ US Patent 6960463 Separation of fibrinogen from plasma proteases	Patent 6960463 was granted and assigned to CSL Limited on November, 2005 by the United States Patent and Trademark Office.		CSL Limited		United States Patent and Trademark Office	6960463	November 1, 2005
	‌ US Patent 7037507 T helper cell epitopes	Patent 7037507 was granted and assigned to CSL Limited on May, 2006 by the United States Patent and Trademark Office.		CSL Limited		United States Patent and Trademark Office	7037507	May 2, 2006
	‌ US Patent 11840573 CD131 binding proteins and uses thereof	Patent 11840573 was granted and assigned to CSL Limited on December, 2023 by the United States Patent and Trademark Office.	CSL Limited	CSL Limited		United States Patent and Trademark Office	11840573	December 12, 2023
	‌ US Patent 11957731 Reconstituted HDL formulation	Patent 11957731 was granted and assigned to CSL Limited on April, 2024 by the United States Patent and Trademark Office.	CSL Limited	CSL Limited		United States Patent and Trademark Office	11957731	April 16, 2024
	‌ US Patent 12071484 Nucleic acids encoding antibodies against human granulocyte-colony stimulating factor receptor (G-CSFR) and method of expressing encoded protein	Patent 12071484 was granted and assigned to CSL Limited on August, 2024 by the United States Patent and Trademark Office.	CSL Limited	CSL Limited		United States Patent and Trademark Office	12071484	August 27, 2024

14 results

0 selected

14 results

0 selected